The Emerging Therapeutic Landscape of ALK Inhibitors in Non-Small Cell Lung CancerValerio Gristina(University of Palermo), Viviana Bazan(University of Palermo)PharmaceuticalsDecember 18, 202010.3390/ph13120474Cited by 74SaveCiteExport RISWatch citationsRelated PapersPD-L1 expression as predictive biomarker in patients with NSCLC: a pooled analysis|Oncotarget|2016|166